News

BGI’s first cloud computing terminal server allows users to access bioinformatics analysis and genomic data in their own laboratories with the advantages of easy to use, high flexibility and user-friendly interface.

After a challenging two-decade hunt, scientists have pinpointed the gene responsible for a rare disease that causes seizures in infancy and sudden, uncontrollable movements in adolescence and early adulthood.

The market research company announced pharmaceutical companies are outsourcing drug research more frequently, and when they do they are handing off larger portions of the operation than ever before, reports.

The company announced that investigational medicine GLPG0778, which is part of its immuno- inflammatory alliance with GlaxoSmithKline, has shown selective effects on a biomarker in a Phase I Proof-of-Mechanism study in healthy volunteers.

The grant will be issued by Grand Challenges in Global Health, who seeks to engage creative minds across scientific disciplines to work on solutions that could lead to breakthrough advances for those in the developing world.

HCPro adds TEMIS semantic content enrichment capabilities.

The companies announced they have completed the enrolment of a 632-patient Phase IIb trial with their long-acting anticoagulant TB-402 (factor VIII inhibitor).

The study missed its endpoints.

The Alliance for Regenerative Medicine (ARM) announced that the briefing will take place on January 10, 2012 in San Francisco.

The Board of Directors of BioSyent Inc. is pleased to announce the appointment of Paul R. Montador to the Company's Board.